慢流动血管形的病理生理学:当前的理解和未解答的问题
Averill Clapp1, Carrie J Shawber2, June K Wu2
1Columbia University Vagelos College of Physicians & Surgeons, New York, NY.
概括
在PI3K/AKT/mTOR和RAS/MAPK路径的遗传变异驱动慢流血管形. 基础和翻译性研究对于开发针对静脉和淋巴细胞形的向治疗至关重要.
科学领域:
- 血管生物学 血管生物学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 缓慢流动的血管形包括静脉,淋巴和淋巴静脉类型.
- 激活PI3K/AKT/mTOR和/或RAS/RAF/MAPK通路的遗传变异与它们的发展有关.
- 药物治疗方法如西罗利斯和阿尔佩利西布是新兴的治疗方法.
研究的目的:
- 审查慢流动血管形的基础和转化研究进展.
- 突出了解改善治疗的基础分子机制的重要性.
主要方法:
- 进行了基础科学出版物的文献综述.
- 使用以下术语搜索了PubMed:"静脉形"",淋巴状形"",淋巴状形"",遗传变异"",遗传突变"",内皮细胞"和"动物模型".
主要成果:
- 对患者组织和内皮细胞的研究揭示了过度增殖和结构破坏.
- 动物模型证实了遗传变异的致病性,并使临床前治疗测试成为可能.
- 基础和翻译研究对于开发有针对性的治疗方法至关重要.
结论:
- 对于缓慢流动的血管形仍然缺乏明确的治疗方法.
- 关键的未回答问题包括基因型-表型相关性和异质性.
- 对形病理生物学的持续研究对于理解遗传贡献和推进治疗方法至关重要.
相关概念视频
Mechanism of Angiogenesis
5.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Autoregulation of Blood Flow
2.4K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.4K
Varicose Veins I: Introduction
9
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
9
Mitral Stenosis I: Introduction
16
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
16
Blood Flow
70.1K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
70.1K


